Press releases
Here you will find our latest press releases
- Changes In Guerbet's Board Of Directors
- Q1 2023 Revenue
- 2022 Annual Results
- 2022 Revenue
- Strategic Priorities 2023
- Intrasense Opens Its Share Capital To The Guerbet Group, Which Announces Its Intent To File A Voluntary Tender Offer Under The Same Price Conditions
- Guerbet announces U.S. Food And Drug Administration (FDA) approval of Elucirem
Media resources
Feel free to download the files you need.
Media relations contact
Actifin is our media relations agency and Mathias Jordan will take care of your request.
+33 (0)1 56 88 11 26